Sterifre Medical Logo

Sterifre Medical Inc.


Weill Cornell Medicine’s Laboratory of Bioregenerative Medicine Surgery (LBMS) will work with Sterifre Medical Inc. toward the commercialization of a new wound therapy device that delivers a patented therapeutic effluent to a wound site via gas-phase resulting in rapid, pain-free wound disinfection for the treatment of acute & chronic wounds. This treatment has practical and biological advantages over liquid and topical treatments and has the flexibility to account for different therapeutic needs. The FuzeHub Manufacturing Innovation Grant will help the team acquire key data necessary to securing FDA approval for a first-in-human study in 2018.


Jason Spector
Associate Professor of Surgery and Otolarngology

View More Awardee Profiles

Exhibitor Inquiry

Attendee Request Form: 2023 Hardware Prototyping Workshop
Thanks for your interest in this resource, fill out the information below to download.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.